Shikimic Acid hmoov

• Precursor rau Anti-Influenza Drug Synthesis

Mechanism of Action: Featuring ib tug tshwj xeeb rau -ntiv nplhaib qauv nrog ntau chiral chaw, Shikimic Acid ua hauj lwm raws li ib tug irreplaceable core precursor rau industrial synthesis ntawm Oseltamivir Phosphate (Tamiflu), ib tug tseem ceeb neuraminidase inhibitor.

Lub Hom Phiaj & Kev Ua Tau Zoo: Oseltamivir tshwj xeeb inhibits neuraminidase nyob rau saum npoo ntawm cov kab mob khaub thuas (Hom A thiab B), tiv thaiv kev tso tawm cov kab mob tshiab tshiab los ntawm cov tswv tsev thiab yog li txwv tsis pub kis kab mob.

• Anti-Thrombotic Effects & Txhim Kho Microcirculation

Mechanism of Action: Los ntawm inhibiting arachidonic acid metabolism, Shikimic Acid ho suppresses ADP- thiab collagen-induced platelet aggregation, txo cov ntshav viscosity, thiab tiv thaiv vascular endothelial hlwb.

Daim Ntawv Thov Kev Kho Mob: Nws ua kom pom tseeb ntawm lub cev - tiv thaiv cov teebmeem hauv kev sim ua qauv ntawm cerebral ischemia-kev raug mob rov qab, myocardial ischemia, thiab microcirculatory ntshawv siab.

• Kev tiv thaiv -Inflammatory, Analgesic & Antioxidant Activities

Kev taw qhia txoj hauv kev: Nws inhibits kev ua haujlwm ntawm NF-kB teeb liab txoj hauv kev, txo qis kev qhia ntawm pro-inflammatory cytokines xws li TNF-alpha thiab IL-1B. Nyob rau tib lub sijhawm, nws nthuav tawm cov haujlwm dawb radical scavenging, txo cov cellular puas vim yog oxidative kev nyuaj siab.

• Natural Sources & Extraction Processes

Cov Chaw Nroj Tsuag: Feem ntau muab los ntawm cov txiv hmab txiv ntoo qhuav, paub tab ntawm lub hnub qub anise (Illicium verum), uas muaj 3% mus rau 7% Shikimic Acid.

Cov txheej txheem rho tawm: Cov txheej txheem ib txwm siv dej lossis cawv rho tawm ua ke nrog macroporous resin adsorption thiab ion- txauv resin purification, ua raws li recrystallization kom tawm los siab - purity hmoov.

• Metabolic Engineering & Microbial Fermentation

Tsob Nroj Nroj Nroj Tsuag: Cov nroj tsuag rho tawm yog txwv los ntawm lub caij nyoog, huab cua, thiab cov khoom siv ua liaj ua teb, ua rau muaj kev hloov pauv loj rau cov khoom siv raw.

Fermentation Frontiers: Los ntawm genetic engineering ntawm Escherichia coli (E. coli) los yog Yarrowia lipolytica, Shikimic Acid tuaj yeem ua ncaj qha rau ntawm qhov ntsuas ntawm siab -cov piam thaj fermentation, txo cov nqi tsim khoom.

• Maj mam Exfoliation & Epidermal Renewal

Keratolytic Regulation: Raws li ib tug polyhydroxy organic acid, Shikimic Acid txhawb lub shedding ntawm laus keratinocytes thiab txhim kho daim tawv nqaij roughness. Qhov tseem ceeb, nws lub peev xwm rau kev ua kom tawv nqaij tawv nqaij yog qis dua li ntawm glycolic acid lossis salicylic acid.

• Sebum Control, Antimicrobial & Anti- Pob txuv Efficacy

Antimicrobial Mechanism: Nws nthuav tawm cov haujlwm zoo kawg nkaus inhibitory tiv thaiv Cutibacterium acnes thiab Malassezia.

Sebum Regulation: Los ntawm suppressing 5alpha-reductase kev ua, nws txo qis sebum secretion, zoo alleviating redness, o, thiab pore congestion nyob rau hauv pob txuv - tawv nqaij.

• Antioxidant & Daim tawv nqaij Brightening

Brightening Pathway: Nws blocks melanin synthesis los ntawm inhibiting tyrosinase kev ua, pab txhim kho hyperpigmentation thiab cov tawv nqaij tsis sib xws.

• Anti-Viral Pharmaceutical Synthesis

Scenario: Ua hauj lwm raws li ib tug irreplaceable core chiral precursor raw khoom rau kev lag luam synthesis ntawm anti-influenza tshuaj Oseltamivir Phosphate (Tamiflu).

Kev Ua Tau Zoo: Siv los tiv thaiv, tswj, thiab kho tus kab mob khaub thuas A thiab B.

• Efficacy Skincare & Personal Care

Scenario: Siv dav hauv cov tshuaj pleev kom zoo nkauj, tiv thaiv- pob txuv / roj- tswj cov gels, cov tawv nqaij tawv tawv - cov tshuaj pleev ib ce, thiab daim tawv nqaij - cov khoom ci ntsa iab.

Kev ua tau zoo: Raws li ib qho yooj yim ntuj polyhydroxy organic acid, nws txhawb cov metabolism ntawm cov laus keratinocytes, inhibits Cutibacterium acnes thiab Malassezia, thiab tswj sebum secretion - nrog rau qhov qis qis dua piv rau cov tshuaj glycolic thiab salicylic acids.

• Anti-Thrombotic & Cardiovascular Tshuaj R&D

Scenario: Siv hauv kev tshawb fawb pharmacological thiab me me -molecule formulation development aiming anti-thrombosis, microcirculation improvement, and cerebral ischemia raug mob tiv thaiv.

Kev ua tau zoo: inhibits platelet aggregation thiab txo cov ntshav viscosity los ntawm suppressing arachidonic acid metabolism.

• Organic Synthesis & Chiral Tsev Blocks (Chiral Pas Dej)

Scenario: Ua hauj lwm hauv kev kawm thiab cov tshuaj lom neeg zoo ua "chiral start material" los tsim cov khoom ntuj tsim, los tiv thaiv -molecules inflammatory, lossis physiologically active derivatives.